Unprovoked recurrent venous thrombosis: prediction by D-dimer and clinical risk factors

J Thromb Haemost. 2008 Apr;6(4):577-82. doi: 10.1111/j.1538-7836.2008.02889.x. Epub 2008 Jan 8.

Abstract

Background: The aim of the study was to determine the predictive value of D-dimer measurement for unprovoked recurrent venous thrombosis and the influence of sex, age and type of first event (unprovoked or provoked).

Methods: Prospective cohort study of 272 patients with a first episode of venous thrombosis that was unprovoked or provoked by a non-surgical trigger.

Findings: The cumulative rate of unprovoked recurrence in patients with a positive D-dimer was 20% at 5 years [5.5/100 patient-years, 95% confidence interval (CI) 3.7-7.8] and in patients with a negative D-dimer 17% (4.1/100 patient-years, 95% CI 2.3-6.9). The rates are not different (hazard ratio 1.3, 95% CI 0.7-2.5). After adjustment for clinical risk factors a positive D-dimer result was significantly associated with an increased risk of unprovoked recurrent thrombosis (hazard ratio 2.0, 95% CI 1.01-3.9). The strongest indicator of risk of recurrence was male sex (hazard ratio 3.3 unadjusted and 2.9 after adjustment). The only determinant of D-dimer in a linear regression model was age (P < 0.001).

Conclusions: The analysis indicates that clinical risk factors confound the association between D-dimer and risk of recurrence and when adjusted for these confounders a positive D-dimer result is significantly associated with unprovoked recurrence. The clinical utility of D-dimer measurement in individual patients should be interpreted in conjunction with clinical risk factors.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use
  • Confounding Factors, Epidemiologic
  • Contraceptives, Oral, Combined
  • Contraceptives, Oral, Hormonal
  • Contraindications
  • Enoxaparin / therapeutic use
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prospective Studies
  • Recurrence
  • Risk Factors
  • Stockings, Compression
  • Thrombophlebitis / blood
  • Thrombophlebitis / epidemiology
  • Thrombophlebitis / therapy
  • Venous Thrombosis / blood
  • Venous Thrombosis / drug therapy
  • Venous Thrombosis / epidemiology*
  • Venous Thrombosis / prevention & control

Substances

  • Anticoagulants
  • Contraceptives, Oral, Combined
  • Contraceptives, Oral, Hormonal
  • Enoxaparin
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D